The biopharma community met at Munich in Germany for BIO-Europe 2023, where attendees from across the world took part in networking events to foster collaboration, last month. With a turnout of nearly 6000 participants and more than 150 exhibitors, the event hosted a number of panel discussions. In collaboration with our parent company, life science […]
Drug discovery and development is a long, costly, and high-risk process that takes over 10 to 15 years with an average cost of over $1 to $2 billion for each new drug to be approved for clinical use. For any pharmaceutical company or academic institution, it is a big achievement to advance a drug candidate […]
In this episode, we explore the synergy of quantum computing and drug discovery with the chief scientific officer and co-founder of Qubit Pharmaceuticals, Jean-Philip Piquemal. Qubit Pharmaceuticals was founded in 2020 with the vision of co-developing, with pharmaceutical and biotech companies, new, more effective, and safer drugs. The company uses its Atlas platform to discover […]
3D printing is capturing attention in the field of medicine of late. With the first 3D-printed drug being approved for the treatment of seizures, eight years ago, it was a consequential moment in healthcare, following which biotechs raced to step up personalized treatment. Now, with Chinese healthcare company Triastek turning heads after announcing promising clinical […]